𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of irinotecan as first-line chemotherapy for patients with advanced colorectal carcinoma

✍ Scribed by José Luis Fírvida; Antonio Irigoyen; Sergio Vázquez-Estévez; Pilar Díz; Manuel Constenla; Joaquín Casal-Rubio; Manuel Valladares-Ayerbes; Javier Castellanos; Rubén Rodríguez; Miquel Balcells

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
103 KB
Volume
91
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of paclitaxel plus carb
A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma
✍ Edith A. Perez; David W. Hillman; Philip J. Stella; James E. Krook; Lynn C. Hart 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

## BACKGROUND. This Phase II multicenter study evaluated the efficacy and toxicity of paclitaxel (200 mg/m 2 by 3-hour infusion) with carboplatin (area under the curve 6 mg/mL per minute) administered every 3 weeks as first-line therapy for women with metastatic breast carcinoma. ## METHODS. Eligi

Paclitaxel-based second-line therapy for
Paclitaxel-based second-line therapy for patients with advanced chemotherapy-resistant bladder carcinoma (M1) : A clinical Phase II study
✍ Thomas Otto; Axel Bex; Susanne Krege; Peter H. Walz; Herbert Rübben 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

and an antimotility factor (acellular pertussis vaccine [APV]) in 18 School, Essen, Germany. patients with cisplatin-and methotrexate-resistant metastatic bladder carcinoma. Intramuscular injection of APV 3 times in the first week, on Days 1, 4, and 7, was